Visual magnification

Visual magnification is the perceived increase in the apparent size of objects or regions of the visual field without any corresponding change in viewing distance.

As a drug effect it is acute and dose-proportional, easing as the substance wears off; this distinguishes it from clinical macropsia, which is a persistent neurological symptom. It ranges from a subtle enlarging of nearby objects to a wholesale swelling of the entire visual scene.

Visual magnification is an uncommon perceptual effect reported across several drug classes. It is most commonly induced at moderate to high doses under psychedelics such as LSD, psilocybin mushrooms, and DMT, and also appears under dissociatives such as dextromethorphan and deliriants such as Amanita muscaria; it has been reported under depressants such as zolpidem, particularly near sleep onset.

Visual magnification is felt as a destabilizing shift in spatial scale: objects that were ordinary moments before appear to loom, their surfaces and edges suddenly prominent. Depth cues remain intact — the enlarged object does not feel closer — creating a quiet perceptual incongruity that is hard to dismiss.

It tends to be intermittent rather than continuous, flickering in and out as attention moves across the visual field. At higher doses, particularly under psychedelics, the effect can encompass the full scene, making familiar surroundings feel vast and architecturally alien.

Visual magnification arises through different pathways depending on the drug class:

• Psychedelics — act on 5-HT2A receptors in visual cortex, disrupting size-constancy computations that normally anchor perceived object dimensions.
• Dissociatives — block NMDA receptors, altering the depth and distance signals the visual system uses to calibrate apparent size.
• Deliriants — cholinergic blockade disrupts acetylcholine signaling in visual processing areas, producing magnification alongside broader perceptual distortions.
• Depressants — GABAergic enhancement at hypnotic doses can transiently destabilize size perception, especially near sleep onset.

How much each pathway contributes in a given case is not fully understood.

Who experiences it, and how strongly, varies widely. It is more common at moderate to high doses and scales with dose across all classes that produce it.

Set and setting play a role — an unfamiliar or visually busy environment tends to heighten it — as does prior sensitivity to visual effects and a disposition toward perceptual absorption. Expecting it appears to draw attention to mild size shifts that might otherwise pass unnoticed. Familiarity with the substance and a calm, uncluttered environment tend to reduce its intensity.